We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

78 hedge funds and large institutions have $63.7M invested in VanEck Biotech ETF in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 26 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less call options, than puts

Call options by funds: $2.85M | Put options by funds: $2.87M

0.93% less ownership

Funds ownership: 20.54% → 19.61% (-0.93%)

7% less funds holding

Funds holding: 84 → 78 (-6)

18% less capital invested

Capital invested by funds: $78M → $63.7M (-$14.3M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

69% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 26

Holders
78
Holders Change
-6
Holders Change %
-7.14%
% of All Funds
1.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
26
Closed
13
Calls
$2.85M
Puts
$2.87M
Net Calls
-$24K
Net Calls Change
-$9.18M

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$2.84M
2
Jane Street
Jane Street
New York
+$1.29M
3
TRCT
Tower Research Capital (TRC)
New York
+$340K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$336K
5
MJRIC
Mogy Joel R Investment Counsel
California
+$155K

Top Sellers

Rank Fund Capital Flow
1
TIA
Traphagen Investment Advisors
New Jersey
-$6.34M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.25M
3
AFG
Albion Financial Group
Utah
-$1.24M
4
Simplex Trading
Simplex Trading
Illinois
-$823K
5
UBS Group
UBS Group
Switzerland
-$640K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
26
Atlas Capital Advisors
Wyoming
$708K – – –
SBH
27
Segall Bryant & Hamill
Illinois
$617K – – –
IFWM
28
Institute for Wealth Management
Colorado
$587K – – –
TC
29
Telemus Capital
Michigan
$534K – – –
FNBOSM
30
First National Bank of South Miami
Florida
$523K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$470K +$340K +2,734 +220%
SB
32
Suntrust Banks
Georgia
$441K +$24.2K +195 +6%
IAMOG
33
Investors Asset Management of Georgia
Georgia
$437K – – –
SC
34
Scotia Capital
Ontario, Canada
$428K – – –
WJWM
35
Williams Jones Wealth Management
New York
$414K +$436K +3,510 New
PAG
36
Private Advisor Group
New Jersey
$388K -$214K -1,720 -34%
Ameriprise
37
Ameriprise
Minnesota
$327K -$364K -2,926 -51%
FFN
38
Focus Financial Network
Minnesota
$263K -$8.33K -67 -3%
MWA
39
MFA Wealth Advisors
Pennsylvania
$212K – – –
FANJ
40
Financial Architects (New Jersey)
New Jersey
$186K – – –
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
$142K – – –
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$141K -$4.35K -35 -3%
AG
43
Advisor Group
Arizona
$112K -$21.8K -175 -16%
Citigroup
44
Citigroup
New York
$93K -$41.8K -336 -30%
IA
45
IFP Advisors
Florida
$88K +$92.6K +745 New
NSIM
46
North Star Investment Management
Illinois
$81K +$85.8K +690 New
EDRH
47
Edmond de Rothschild Holding
Switzerland
$76K – – –
CG
48
Cutler Group
California
$74K -$4.97K -40 -6%
AF
49
Advisornet Financial
Minnesota
$71K – – –
KTC
50
Kistler-Tiffany Companies
Pennsylvania
$62K – – –
1
2
3 4

BBH Hedge Fund Activity: Q3 2019 in Review

78 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2019, worth a combined $63.7M — down 18% from $78M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BBH and 8 opened new positions — a net loss of 5 holders — while 26 trimmed existing stakes and 8 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $2.84M. The largest seller was Traphagen Investment Advisors, exiting entirely with an estimated $6.34M sold.

  • 78 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2019, down from 84 in Q2 2019.
  • Funds reported $63.7M of VanEck Biotech ETF stock for Q3 2019, down 18% quarter-over-quarter.
  • 8 funds opened new VanEck Biotech ETF positions in Q3 2019 and 13 closed out, a net change of -5 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2019 was Virtu Financial, an estimated $2.84M added.
  • The largest VanEck Biotech ETF seller in Q3 2019 was Traphagen Investment Advisors, an estimated $6.34M sold.

Based on aggregated 13F filings for Q3 2019.